Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrofuran SCHEMBL4337006 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| Dioxane SCHEMBL9508711 | 0.88 | ALDH1A1 (0.62) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| Oxirane SCHEMBL8581231 | 0.85 | ALDH1A1 (0.67) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| SCHEMBL28288392 | 0.84 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| Tetrahydrofuran SCHEMBL10761380 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| SCHEMBL9508706 | 0.83 | ALDH1A1 (0.56) | ALDH1A1TSHRHSD17B10TDP1 | |
| Tetrahydrofuran SCHEMBL165529 | 0.82 | — | — | |
| Pyridine SCHEMBL15233785 | 0.82 | TSHR (0.37) | ALDH1A1TSHRTDP1MEN1KMT2A | |
| Tetrahydrofuran SCHEMBL29171726 | 0.81 | ALDH1A1 (0.53) | ALDH1A1TSHRHSD17B10TDP1SMN1; SMN2 | |
| Tetrahydrofuran SCHEMBL28969290 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRSMN1; SMN2GLALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112645994-B | Extraction process of salidroside | 湖州柳荫生物科技有限公司 | 2022-08-26 | — | — | CN | claimed |
| CN-112645994-A | Extraction process of salidroside | 湖州柳荫生物科技有限公司 | 2021-04-13 | — | — | CN | claimed |
| CN-103408554-A | Hypertensive activity reducing pyrrole coumarins compound and preparation method thereof | UNIV XI AN JIAOTONG | 2013-11-27 | — | — | CN | claimed |
| WO-2024143276-A1 | OLIGONUCLEOTIDE PRODUCTION METHOD | 住友化学株式会社 | 2024-07-04 | — | — | WO | disclosed |
| CN-113677432-B | Inorganic porous carrier and method for producing nucleic acid using same | 住友化学株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-118147134-A | SiRNA for targeted regulation and control of PCSK9 gene expression and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-113646083-B | Inorganic porous carrier and method for producing nucleic acid using same | 住友化学株式会社 | 2024-06-07 | — | — | CN | disclosed |
| CN-118109463-A | SiRNA targeting PCSK9 gene and application thereof | 北京悦康科创医药科技股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| EP-4368627-A1 | COMPOSITION CONTAINING NUCLEIC ACID OLIGOMER | Sumitomo Chemical Company, Limited (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-117980285-A | Process for producing purified dichloroacetic acid | 住友化学株式会社 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024089953-A1 | METHOD FOR PRODUCING OLIGONUCLEOTIDE | 住友化学株式会社 | 2024-05-02 | — | — | WO | disclosed |
| CN-1950417-A | Polythiourethanes | UBE IND LTD A CORP OF JAPAN (JP) | 2007-04-18 | — | — | CN | disclosed |
| EP-1180113-A4 | OLIGONUCLEOTIDES HAVING A-DNA FORM AND B-DNA FORM CONFORMATIONAL GEOMETRY | ISIS PHARMACEUTICALS INC (US) | 2002-09-18 | — | — | EP | disclosed |
| EP-1180113-A1 | OLIGONUCLEOTIDES HAVING A-DNA FORM AND B-DNA FORM CONFORMATIONAL GEOMETRY | ISIS PHARMACEUTICALS, INC. (US) | 2002-02-20 | — | — | EP | disclosed |
| WO-2000066609-A1 | OLIGONUCLEOTIDES HAVING A-DNA FORM AND B-DNA FORM CONFORMATIONAL GEOMETRY | ISIS PHARMACEUTICALS, INC. (US) | 2000-11-09 | — | — | WO | disclosed |
| US-6004826-A | Repair-mediated process for amplifying and detecting nucleic acid sequences | Segev, David | 1999-12-21 | — | — | US | disclosed |
| EP-0425563-B1 | PROCESS FOR AMPLIFYING AND DETECTING NUCLEIC ACID SEQUENCES | SEGEV DAVID (IL) | 1996-05-15 | — | — | EP | disclosed |
| EP-0425563-A4 | PROCESS FOR AMPLIFYING AND DETECTING NUCLEIC ACID SEQUENCES | — | 1992-06-10 | — | — | EP | disclosed |
| EP-0425563-A1 | PROCESS FOR AMPLIFYING AND DETECTING NUCLEIC ACID SEQUENCES. | SEGEV DIAGNOSTICS INC (US) | 1991-05-08 | — | — | EP | disclosed |
| WO-1990001069-A1 | PROCESS FOR AMPLIFYING AND DETECTING NUCLEIC ACID SEQUENCES | SEGEV DIAGNOSTICS, INC. (US) | 1990-02-08 | — | — | WO | disclosed |